Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen

Abstract PEG‐asparaginase is used as a treatment for Philadelphia‐negative acute lymphoblastic leukemia. In pediatric studies, triglycerides (TGs) were affected more by PEG‐asparaginase than by native L‐asparaginase (10.0% vs. 5.5%). We conducted a retrospective study to determine the safety of re‐c...

Full description

Bibliographic Details
Main Authors: Ibrahim Al Nabhani, Claire Andrews, Jad Sibai, Eshetu Atenafu, Taylor Young, Steven M. Chan, Vikas Gupta, Dawn Maze, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Hassan Sibai
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:eJHaem
Subjects:
Online Access:https://doi.org/10.1002/jha2.607
_version_ 1827318965552021504
author Ibrahim Al Nabhani
Claire Andrews
Jad Sibai
Eshetu Atenafu
Taylor Young
Steven M. Chan
Vikas Gupta
Dawn Maze
Aaron D. Schimmer
Andre C. Schuh
Karen Yee
Hassan Sibai
author_facet Ibrahim Al Nabhani
Claire Andrews
Jad Sibai
Eshetu Atenafu
Taylor Young
Steven M. Chan
Vikas Gupta
Dawn Maze
Aaron D. Schimmer
Andre C. Schuh
Karen Yee
Hassan Sibai
author_sort Ibrahim Al Nabhani
collection DOAJ
description Abstract PEG‐asparaginase is used as a treatment for Philadelphia‐negative acute lymphoblastic leukemia. In pediatric studies, triglycerides (TGs) were affected more by PEG‐asparaginase than by native L‐asparaginase (10.0% vs. 5.5%). We conducted a retrospective study to determine the safety of re‐challenging adult patients with PEG‐asparaginase after experiencing an episode of severe hypertriglyceridemia (>1000 mg/dl or 11.4 mmol/L). The incidence of hypertriglyceridemia associated with PEG‐asparaginase in adult patients was high (67.5%). Therefore, checking TGs at baseline and monitoring levels while receiving PEG‐asparaginase need to be considered and studied in prospective studies. However, in patients with hypertriglyceridemia not complicated by acute pancreatitis, re‐challenging is safe once TG levels normalize.
first_indexed 2024-03-12T14:07:10Z
format Article
id doaj.art-e50e7e9e08b74513abd28ce4a7d9068c
institution Directory Open Access Journal
issn 2688-6146
language English
last_indexed 2024-04-25T00:10:40Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series eJHaem
spelling doaj.art-e50e7e9e08b74513abd28ce4a7d9068c2024-03-13T13:30:48ZengWileyeJHaem2688-61462023-02-014123223510.1002/jha2.607Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimenIbrahim Al Nabhani0Claire Andrews1Jad Sibai2Eshetu Atenafu3Taylor Young4Steven M. Chan5Vikas Gupta6Dawn Maze7Aaron D. Schimmer8Andre C. Schuh9Karen Yee10Hassan Sibai11Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre University Health Network Toronto Ontario CanadaAbstract PEG‐asparaginase is used as a treatment for Philadelphia‐negative acute lymphoblastic leukemia. In pediatric studies, triglycerides (TGs) were affected more by PEG‐asparaginase than by native L‐asparaginase (10.0% vs. 5.5%). We conducted a retrospective study to determine the safety of re‐challenging adult patients with PEG‐asparaginase after experiencing an episode of severe hypertriglyceridemia (>1000 mg/dl or 11.4 mmol/L). The incidence of hypertriglyceridemia associated with PEG‐asparaginase in adult patients was high (67.5%). Therefore, checking TGs at baseline and monitoring levels while receiving PEG‐asparaginase need to be considered and studied in prospective studies. However, in patients with hypertriglyceridemia not complicated by acute pancreatitis, re‐challenging is safe once TG levels normalize.https://doi.org/10.1002/jha2.607acute lymphoblastic leukemiaacute pancreatitishypertriglyceridemiaPEG‐asparaginasetoxicity
spellingShingle Ibrahim Al Nabhani
Claire Andrews
Jad Sibai
Eshetu Atenafu
Taylor Young
Steven M. Chan
Vikas Gupta
Dawn Maze
Aaron D. Schimmer
Andre C. Schuh
Karen Yee
Hassan Sibai
Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
eJHaem
acute lymphoblastic leukemia
acute pancreatitis
hypertriglyceridemia
PEG‐asparaginase
toxicity
title Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
title_full Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
title_fullStr Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
title_full_unstemmed Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
title_short Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
title_sort safety of re challenging adults with acute lymphoblastic leukemia with peg asparaginase induced severe hypertriglyceridemia when treated with a pediatric inspired regimen
topic acute lymphoblastic leukemia
acute pancreatitis
hypertriglyceridemia
PEG‐asparaginase
toxicity
url https://doi.org/10.1002/jha2.607
work_keys_str_mv AT ibrahimalnabhani safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT claireandrews safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT jadsibai safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT eshetuatenafu safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT tayloryoung safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT stevenmchan safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT vikasgupta safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT dawnmaze safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT aarondschimmer safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT andrecschuh safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT karenyee safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen
AT hassansibai safetyofrechallengingadultswithacutelymphoblasticleukemiawithpegasparaginaseinducedseverehypertriglyceridemiawhentreatedwithapediatricinspiredregimen